Finance

Lists
Q2 2026 earnings • released • EPS beat +8.70% • Revenue beat +3.81%
See results
SHC:NASDAQ
Sotera Health Co
$18.97
+0.58%
(+0.11) 1D
$18.97
0.00% (0.00)
After hours
Closed: Aug 10, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SHC...
Open
$18.66
High
$19.01
Low
$18.60
Mkt. cap
5.41B
Avg. vol.
3.02M
Volume
3.29M
P/E ratio
46.24
52-wk high
$19.84
52-wk low
$13.09
EPS
$0.41
Beta
1.77
Shares outstanding
285.38M
No. of employees
3K
Open
$18.66
High
$19.01
Low
$18.60
Mkt. cap
5.41B
Avg. vol.
3.02M
Volume
3.29M
P/E ratio
46.24
52-wk high
$19.84
52-wk low
$13.09
EPS
$0.41
Beta
1.77
Shares outstanding
285.38M
No. of employees
3K
News stories
From web sources and news partners
About Sotera Health Co
CEO-
Employees3K
Founded2015
HeadquartersBroadview Heights, Ohio, United States
SectorHealth care
Websitesoterahealth.com
Analyst ratings
Based on 6 analysts giving stock ratings to SHC in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for SHC in the last 3 months.
Highest
Current $18.97
$25.00 (+31.79%)
Average
$23.67 (+24.78%)
Lowest
$22.00 (+15.97%)
Analyst
Recommendation
Action
Price target
Projected
Date
Evie Koslosky
Goldman Sachs
Buy
Maintained
$24.00
+26.5%
08/06/2026
Jason Bednar
Piper Sandler
Buy
Maintained
$25.00
+31.8%
08/07/2026
Sean Dodge
BMO Capital
Buy
Reiterated
$22.00
+16%
08/06/2026
Ryan Halsted
RBC Capital
Buy
Reiterated
$24.00
+26.5%
08/06/2026
Patrick B Donnelly
Citi
Buy
Maintained
$25.00
+31.8%
08/07/2026
Luke Sergott
Barclays
Buy
Maintained
$22.00
+16%
08/07/2026
Max Smock
William Blair
Buy
Reiterated
-
-
05/05/2026
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.26 / $0.24
+8.70%beat
Revenue / Est. (USD)
321.38M / 309.57M
+3.81%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
311.31M
303.44M
280.04M
321.38M
Cost of goods sold
133.75M
137.52M
132.98M
143.41M
Cost of revenue
133.75M
137.52M
132.98M
143.41M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
48.19M
54.42M
56.50M
52.97M
Operating expense
51.28M
57.44M
59.53M
55.98M
Total operating expenses
185.03M
194.96M
192.50M
199.39M
Operating income
126.28M
108.48M
87.54M
121.98M
Other non operating income
-3.49M
7.63M
-899.00K
1.01M
EBT including unusual items
72.94M
70.50M
42.61M
78.05M
EBT excluding unusual items
85.17M
79.50M
52.47M
92.34M
Income tax expense
24.54M
35.65M
16.02M
24.41M
Effective tax rate
33.64%
50.57%
37.60%
31.27%
Other operating expenses
-
-
-
-
Net income
48.40M
34.85M
26.59M
53.64M
Net profit margin
15.55%
11.48%
9.49%
16.69%
Earnings per share
0.26
0.26
0.18
0.26
Interest and investment income
-
-
-
-
Interest expense
-39.15M
-35.05M
-34.74M
-34.40M
Net interest expenses
-39.15M
-35.05M
-34.74M
-34.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
155.24M
141.59M
119.03M
156.01M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps